CARI Guidelines: Management of lipid-lowering therapy in CKD

Published by David Tunnicliffe on Dec 6, 2020

Disclaimer

Sponsors

Contact

Abstract

Language

en

PICOS

PICO 3.1

Population
People with chronic kidney disease (eGFR ≥15 mL/min/1.73m^2)
Intervention
Statin therapy
Comparator
Placebo or standard of care
Outcomes

PICO 3.2

Population
People with chronic kidney disease (eGFR 15 - 90 mL/min/1.73m^2)
Intervention
Statin therapy plus ezetimibe
Comparator
Statin therapy
Outcomes